As of 2025-12-27, the Relative Valuation of Cymabay Therapeutics Inc (CBAY) is (14.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.48 USD, the upside of Cymabay Therapeutics Inc based on Relative Valuation is -144.0%.
The range of the Relative Valuation is (10.78) - (14.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 16.1x | 14.2x |
| Forward P/E multiples | 11.7x - 18.7x | 17.0x |
| Fair Price | (10.78) - (14.74) | (14.30) |
| Upside | -133.2% - -145.4% | -144.0% |
| Date | P/E |